Drug Therapies for the Management of Sickle Cell Disease [version 1; peer review: 2 approved]
Sickle cell disease (SCD) afflicts millions of people worldwide but is referred to as an orphan disease in the United States. Over the past several decades, there has been an increasing understanding of the pathophysiology of SCD and its complications. While most individuals with SCD in resource-ric...
Main Authors: | Parul Rai, Kenneth I. Ataga |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-06-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-592/v1 |
Similar Items
-
Biomarkers and recent advances in the management and therapy of sickle cell disease [version 1; referees: 2 approved]
by: Marilyn J. Telen
Published: (2015-10-01) -
Recent advances in managing Peyronie’s disease [version 1; peer review: 2 approved]
by: Asrit Babu, et al.
Published: (2020-05-01) -
Understanding and management of gestational trophoblastic disease [version 1; peer review: 2 approved]
by: Fen Ning, et al.
Published: (2019-04-01) -
Clinical Implications of the Association of Fetal Hemoglobin with Peripheral Oxygen Saturation in Sickle Cell Disease
by: Osheiza Abdulmalik, et al.
Published: (2017-10-01) -
Emerging therapies in the management of macular edema: a review [version 1; peer review: 2 approved]
by: Riccardo Sacconi, et al.
Published: (2019-08-01)